Category Technical Cooperation/ Technology Transfer

High-Level UN Initiative On Global Public Health Gap Holds Landmark Hearing

An initiative of the United Nations secretary general yesterday gathered what could be described as an assembly of many of the world’s best thinkers and practitioners on public health and intellectual property rights. Industry, activists, academics, international organisations, and possibly some governments poured out their views for nearly seven hours – at times coming to tears and tension – shepherded by an astute moderator, as they responded to the call to take a longstanding debate on medicines access and high prices to a breakthrough.

UN Global Dialogue On Innovation And Access To Medicines This Week

The United Nations Secretary General’s High-Level Panel on Access to Medicines is holding a global dialogue this month, attended by governments, civil society, industry and academia, to discuss potential solutions to promote innovation and at the same time increase access to medicines. The first public dialogue session is this week, on 10 March in London.

As South Sudan Joins East African Community, Some Experts Worry Over Its IP Laws

NAIROBI, Kenya -- Experts and activists are raising concern over the lack of proper intellectual property laws in South Sudan, as the world’s newest nation’s admission into the East Africa Community (EAC) spurs anticipation of increased investment.

TRIPS Council: Differing Views On IP Education; New Database Project Launched

Discussions on the worth of intellectual property for innovation and development have been a recurring agenda item during recent meetings of the World Trade Organization committee on intellectual property. This week, education and how it can raise awareness of IP was discussed with WTO members presenting their national experiences, and some developing countries warning against colluding IP and innovation.

Uganda In Clinical Trials For Ebola Vaccine

KAMPALA, Uganda -- An Ebola vaccine trial is underway in Uganda, as the global search for an effective vaccine continues. The vaccine candidate was co-developed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the United States National Institutes of Health (NIH), and GlaxoSmithKline (GSK), a United Kingdom-based pharmaceutical company.

East Africa Pharma Summit Examines Linkages Between Domestic Policies, Industry, Trade And Health

NAIROBI, Kenya -- As the budding East African pharmaceutical industry shows clear gains , experts at a pharmaceutical summit in Kenya underlined the sector as key to tackling challenges related to access to essential medicines in the region.

IP And Innovation, Non-Violation Complaints On TRIPS Council Menu

The now-familiar item of intellectual property and innovation is on the agenda for next week’s regular meeting of the intellectual property committee of the World Trade Organization. This time under the item, a range of developed countries have proposed to discuss education and diffusion, and Switzerland has put forward a paper on nurturing a culture of innovation.

UAEM’s Re:Route – New Mapping Tool For Alternative Health R&D Models

Re:Route, a mapping tool that lays out the research and development (R&D) landscape of innovation and financing for medicines, has been launched by the Universities Allied for Essential Medicines (UAEM). It is a one-stop place for the alternative biomedical research and development landscape.

Questions Over WIPO Statements At UN Secretary-General’s Panel On Access To Medicines

The World Intellectual Property Organization, a specialized agency of the United Nations, was unique among Geneva-based UN agencies for offering views at both recent meetings of the UN High-Level Panel on Access to Medicines held in Geneva and New York this month. Now WIPO has come under criticism from public health advocates for the views it gave.